课题基金 / 基金详情

项目摘要

项目成果

JOEL M GOODMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Peroxisomes are essential organelles that are found in virtually all eukaryotic cells. They catalyze a variety of oxidations, metabolic interconversions and biosynthetic reactions. Defects in peroxisomal assembly in humans are the coarse of the catastrophic childhood diseases Zellweger syndrome and neonatal adrenoleukodystrophy which lead to death at an early age. Although much is now known about the functions of peroxisomes, considerably less is understood about the assembly of these organelles. The long-term goal of this research is the understanding of the molecular interactions responsible for the targeting, membrane translocation or assembly, and maturation of peroxisomal proteins. Two yeast species Candida boidinii and Saccharomyces cerevisiae will be utilized for their strengths in characterizing three aspects of peroxisomal assembly. (1) Targeting sequences on a peroxisomal integral membrane protein, PMP47, will be identified. Fusions of this protein from the methylotrophic yeast C boidinii, and dihydrofolate reductase will be constructed. Their sorting in vivo into the peroxisomal membrane of S. cerevisiae will be monitored by techniques of cell fractionation and immunoblotting, and immunomicroscopy. Nested deletions in the PMP47 part of the fusions will ge generated to identify putative targeting sequences. Such sequences will be confirmed in separate constructions. Allowed alterations of the targeting signal(s) will be determined. Antibodies against PMP47 and dihydrofolate reductase will be used in these studies. (2) The function of BP48, a protein that specifically and competitively binds to a peroxisomal targeting sequence in vitro, will be analyzed. BP48 will be purified by affinity chromatography and antibodies will be raised against it. These will be used to localize the protein within the cell. A pulse-chase and co-immunoprecipitation protocol, using the BP48 antibodies will be performed to determine if binding to newly synthesized peroxisomal proteins occurs in vivo. The corresponding gene will be isolated and a disruption strain in S. cerevisiae will be constructed to further assess the importance of this protein in peroxisomal assembly. (3) The function of the three abundant peroxisomal membrane proteins in S. cerevisiae, scPMP24, scPMP31, and scPMP32, will be proved. No functions have yet been shown for any specific bona fide peroxisomal integral membrane protein. The genes encoding these proteins will be cloned wither using peptide sequences from the purified proteins or by homology to proteins of similar size in peroxisomal membranes of C. Boidinii. Clues to function of the scPMPs may be obtained from the inferred primary structures. Strains containing the disrupted genes, if viable, will be studied by a variety of enzymatic, morphological, and biosynthetic assays to assess the role of these proteins on peroxisomal assembly and function. If appropriate, the genes will be placed on a regulated promoter to study effects of different levels of expression on function. If no phenotype is observed, strains containing a combination of disruptions will be generated to test for redundant functions. Ultimately, hypotheses of function will be tested in reconstituted systems. The genes will also be useful for future studies of the assembly and topology of this class of proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Simple Cellular Model for Lipodystrophy
  • 批准号:
    8000241
  • 项目类别:
  • 资助金额:
    $3.15万
  • 财政年份:
    2010
  • 负责人:
    JOEL M GOODMAN
  • 依托单位:
A Simple Cellular Model for Lipodystrophy
  • 批准号:
    8440076
  • 项目类别:
  • 资助金额:
    $31.8万
  • 财政年份:
    2008
  • 负责人:
    JOEL M GOODMAN
  • 依托单位:
A Simple Cellular Model for Lipodystrophy
  • 批准号:
    7827986
  • 项目类别:
  • 资助金额:
    $31.09万
  • 财政年份:
    2008
  • 负责人:
    JOEL M GOODMAN
  • 依托单位:
A Simple Cellular Model for Lipodystrophy
  • 批准号:
    10153463
  • 项目类别:
  • 资助金额:
    $33.37万
  • 财政年份:
    2008
  • 负责人:
    JOEL M GOODMAN
  • 依托单位:
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: